Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Apr;105(4):1009–1013. doi: 10.1111/j.1476-5381.1992.tb09093.x

Effect of metformin on glucose metabolism in the splanchnic bed.

C J Bailey 1, C Wilcock 1, C Day 1
PMCID: PMC1908709  PMID: 1504710

Abstract

1. Use of the antihyperglycaemic agent, metformin, is often associated with a small rise in circulating lactate. This study investigates the source of the lactate and examines the effect of metformin on glucose metabolism by the intestine and liver of rats. 2. Changes in plasma glucose and lactate were measured in the inferior vena cava (IVC), hepatic portal vein (HPV), hepatic vein (HV) and aorta (A) after intrajejunal administration of metformin (50 and 250 mg kg-1) without and with glucose (2 g kg-1). 3. Metformin 250 mg kg-1 reduced the hyperglycaemic response to a glucose challenge, associated with a greater reduction of glucose concentrations in the HPV (average decrease of 33% at 60 and 120 min) than at other sites. 4. Both doses of metformin increased lactate concentrations in the glucose-loaded state: the highest concentration (2.5 fold increase) was recorded in the HPV 60 min after administration of 250 mg kg-1 metformin, with a high lactate concentration persisting in the HV at 120 min. Metformin 250 mg kg-1 also increased lactate concentrations in the basal state, with highest concentrations (2 fold increase) in the HPV. 5. Two hours after intrajejunal administration of metformin, 50 mg kg-1, rings of tissue from the small intestine showed an average 22% decrease in glucose oxidation ([14C]-glucose conversion to 14CO2) and a 10% increase in lactate production. Since glucose metabolism in the gut is predominantly anaerobic, metformin caused an overall 9.5% increase of intestinal glucose utilization.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
1009

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bailey C. J. Metformin revisited: its actions and indications for use. Diabet Med. 1988 May-Jun;5(4):315–320. doi: 10.1111/j.1464-5491.1988.tb00996.x. [DOI] [PubMed] [Google Scholar]
  2. Bailey C. J., Nattrass M. Treatment--metformin. Baillieres Clin Endocrinol Metab. 1988 May;2(2):455–476. doi: 10.1016/s0950-351x(88)80043-0. [DOI] [PubMed] [Google Scholar]
  3. Bailey C. J., Puah J. A. Effect of metformin on glucose metabolism in mouse soleus muscle. Diabete Metab. 1986 Aug;12(4):212–218. [PubMed] [Google Scholar]
  4. Berry M. N., Friend D. S. High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol. 1969 Dec;43(3):506–520. doi: 10.1083/jcb.43.3.506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Campbell I. W., Duncan C., Patton N. W., Broadhead T., Tucker G. T., Woods H. F. The effect of metformin on glycaemic control, intermediary metabolism and blood pressure in non-insulin-dependent diabetes mellitus. Diabet Med. 1987 Jul-Aug;4(4):337–341. doi: 10.1111/j.1464-5491.1987.tb00895.x. [DOI] [PubMed] [Google Scholar]
  6. Frayn K. N., Adnitt P. I. Effects of metformin on glucose uptake by isolated diaphragm from normal and diabetic rats. Biochem Pharmacol. 1972 Dec 1;21(23):3153–3162. doi: 10.1016/0006-2952(72)90142-6. [DOI] [PubMed] [Google Scholar]
  7. Jackson R. A., Hawa M. I., Jaspan J. B., Sim B. M., Disilvio L., Featherbe D., Kurtz A. B. Mechanism of metformin action in non-insulin-dependent diabetes. Diabetes. 1987 May;36(5):632–640. doi: 10.2337/diab.36.5.632. [DOI] [PubMed] [Google Scholar]
  8. Lorch E. Inhibition of intestinal absorption and improvement of oral glucose tolerance by biguanides in the normal and in the streptozotocin-diabetic rat. Diabetologia. 1971 Jun;7(3):195–203. doi: 10.1007/BF01212553. [DOI] [PubMed] [Google Scholar]
  9. Nosadini R., Avogaro A., Trevisan R., Valerio A., Tessari P., Duner E., Tiengo A., Velussi M., Del Prato S., De Kreutzenberg S. Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes. Diabetes Care. 1987 Jan-Feb;10(1):62–67. doi: 10.2337/diacare.10.1.62. [DOI] [PubMed] [Google Scholar]
  10. Pentikäinen P. J., Neuvonen P. J., Penttilä A. Pharmacokinetics of metformin after intravenous and oral administration to man. Eur J Clin Pharmacol. 1979 Sep;16(3):195–202. doi: 10.1007/BF00562061. [DOI] [PubMed] [Google Scholar]
  11. Prager R., Schernthaner G., Graf H. Effect of metformin on peripheral insulin sensitivity in non insulin dependent diabetes mellitus. Diabete Metab. 1986 Dec;12(6):346–350. [PubMed] [Google Scholar]
  12. Pénicaud L., Hitier Y., Ferré P., Girard J. Hypoglycaemic effect of metformin in genetically obese (fa/fa) rats results from an increased utilization of blood glucose by intestine. Biochem J. 1989 Sep 15;262(3):881–885. doi: 10.1042/bj2620881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Stevens J. F. Determination of glucose by an automatic analyser. Clin Chim Acta. 1971 Apr;32(2):199–201. doi: 10.1016/0009-8981(71)90332-9. [DOI] [PubMed] [Google Scholar]
  14. Tucker G. T., Casey C., Phillips P. J., Connor H., Ward J. D., Woods H. F. Metformin kinetics in healthy subjects and in patients with diabetes mellitus. Br J Clin Pharmacol. 1981 Aug;12(2):235–246. doi: 10.1111/j.1365-2125.1981.tb01206.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wilcock C., Bailey C. J. Reconsideration of inhibitory effect of metformin on intestinal glucose absorption. J Pharm Pharmacol. 1991 Feb;43(2):120–121. doi: 10.1111/j.2042-7158.1991.tb06645.x. [DOI] [PubMed] [Google Scholar]
  16. Wilcock C., Bailey C. J. Sites of metformin-stimulated glucose metabolism. Biochem Pharmacol. 1990 Jun 1;39(11):1831–1834. doi: 10.1016/0006-2952(90)90136-9. [DOI] [PubMed] [Google Scholar]
  17. Wilcock C., Wyre N. D., Bailey C. J. Subcellular distribution of metformin in rat liver. J Pharm Pharmacol. 1991 Jun;43(6):442–444. doi: 10.1111/j.2042-7158.1991.tb03507.x. [DOI] [PubMed] [Google Scholar]
  18. Wollen N., Bailey C. J. Inhibition of hepatic gluconeogenesis by metformin. Synergism with insulin. Biochem Pharmacol. 1988 Nov 15;37(22):4353–4358. doi: 10.1016/0006-2952(88)90617-x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES